mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-09 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-09 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-09 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-07 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-07 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-07 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-06 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
4e-06 |